CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Dexcom G5 Continuous Glucose Monitor +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03028220
NCT03028220N/ACompleted
CompareCT.gov

Impact on Hypoglycaemia Awareness of Real Time CGM and Intermittent Continuous

Imperial College London·interventional·Posted Jan 23, 2017·Updated Nov 13, 2019

In Brief

A clinical study evaluating Dexcom G5 Continuous Glucose Monitor and Abbott Freestyle Libre for Type 1 Diabetes Mellitus With Hypoglycemia and 2 related conditions. Completed, enrolled 40 participants.

Detailed Summary

This clinical study proposes to assess the impact of Libre on frequency, duration and severity of hypoglycaemia, compared with the Dexcom G5 realtime CGM and will focus on people with impaired awareness of hypoglycaemia.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsType 1 Diabetes Mellitus With Hypoglycemia, Impaired Awareness of Hypoglycemia, Type1diabetes
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJan 23, 2017
Enrollment StartJan 1, 2016
Primary CompletionFeb 1, 2017
Study CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 9.4 years ago

Interventions

Dexcom G5 Continuous Glucose Monitordevice

Real time continuous glucose sensor connected to monitor providing data and alarms and alerts for glucose trends and values

Abbott Freestyle Libredevice

Continuous glucose recording device which reports glucose concentration and trend on demand, along with a retrospective review of the last 8 hours glucose data